FIGURE

Fig. 6

ID

ZDB-FIG-100309-51

Publication

Poon et al., 2010 - Zebrafish cardiac enhancer trap lines: New tools for in vivo studies of cardiovascular development and disease

Other Figures

All Figure Page

Back to All Figure Page

Fig. 6

Developmental changes in CET lines with early BA-specific expression. A: EGFP expression in the BA and ventral aorta (VA) in wildtype 3-dpf ET27. B: smo mutation affects the ventral aorta, but not the domain of EGFP expression corresponding to BA. C, C′: ET27 adult heart sections shown at low (C) and high (C′) magnification. D: ET31 embryonic expression in BA. E, E′, E″: Cardiac valves; VB (E′) and AV (E″) marked in adult heart of ET31 shown on F-actin-stained sections. F: BA restricted embryonic expression of GW2C. G: GW2C adult heart sections at low magnification. G′, H: Serial sections of VB valve showing its different morphology at high magnification. I, I′: ET33-1A adult heart sections shown at low (I) and high (I″) magnification, for comparison of endocardal cell morphology in BA with ET27 (C′). A, B, D, F: Ventral view at 3dpf; C, C′: Sections of the adult heart immunostained for EGFP and MF20. E′, E″, H, I: Sections counterstained with F-actin. A-V, atrio-ventricular valve; BA, bulbus arteriosus; VB, ventriculo-bulbar valve; V, ventricle.

Expression Data

Gene:	EGFP
Antibody:	Ab12-GFP
Fish:	sqet27Et sqet31Et sqgw2CEt smo^{unspecified/unspecified}; sqet27Et
Anatomical Terms:	atrioventricular valve bulbus arteriosus ventral aorta ventriculo bulbo valve
Stage Range:	Protruding-mouth to Adult

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Dev. Dyn.